Author/Authors :
Bakkar Sohail نويسنده Division of Endocrine Surgery, Department of Surgical Pathology, University Hospital of Pisa, Via Paradisa 2, 56124 Pisa, Italy , Miccoli Paolo نويسنده Division of Endocrine Surgery, Department of Surgical
Pathology, University Hospital of Pisa, Via Paradisa 2, 56124 Pisa,
Italy
Abstract :
Background In the era of minimal access thyroid surgery, the terms
minimal access and minimally invasive are often used interchangeably and
in most instances this is far from being accurate. The aim of this
article is to examine the characteristics and potential of one of the
first minimal access thyroid procedures described; minimally invasive
video-assisted thyroidectomy (MIVAT). Methods The purpose of this
article was obtained by almost two decades of experiences with the
procedure at the authors’ center, and a systemic literature review was
undertaken of all available medical literature to evaluate available
literature by conducting a PubMed search limited to articles originally
written in English language between the years 1997 and 2016. The search
was limited by using the terms: minimally invasive thyroid surgery,
video-assisted, endoscopic, and robotic thyroidectomy. The procedure’s
design, radicality and safety, learning curve, cost, advantages and
disadvantages were addressed. MIVAT’s potential as a surgical tool for
thyroid pathology was also addressed by evaluating its indications,
contraindications, and limitations. Results MIVAT is a gasless hybrid
procedure that is comparable to conventional thyroidectomy (CT) in terms
of radicality and safety, with the added advantage of reduced early
postoperative voice and swallowing symptoms. MIVAT has a relatively
rapid learning curve with an additional advantage over other minimal
access procedures; the ability of being adopted by the low-volume
surgeon at a cost and time comparable to CT, but with improved patient
satisfaction. Furthermore, it is non-inferior to procedures free of a
neck scar in terms of patient satisfaction. MIVAT’s main drawback is
that it is limited by its strict selection criteria. It is a viable
treatment option for all types of thyroid pathologies. However, its role
in therapeutic neck dissection remains to be validated. Conclusions
MIVAT is a safe and effective procedure which is obviously described in
its name “minimally invasive”. It seems that in the era of innovative
technologies and scarless-in-the neck thyroid surgery, MIVAT is here to
stay.